Recognizing disease activity earlier

Sjögren’s disease extends far beyond dryness. Early identification of systemic disease activity can make a meaningful difference—for both you and your patients—in managing the disease and preventing complications. 

Your sicca plus patients—those with sicca symptoms plus involvement of 1 or more organs or systems—may be candidates for biologic therapy. This simple, practical framework helps guide comprehensive patient assessment, uncovering those who may be biologic-ready and enabling timely, targeted intervention.

Explore the patient cases below to identify sicca plus patients in your practice